Simplified Language for Autism
(PALS Trial)
Trial Summary
What is the purpose of this trial?
The long-term study goal is to experimentally evaluate the components (and likely active ingredients) of early language interventions for young children with ASD. The overall objective is to determine how single-word and telegraphic simplification affects real-time language processing and word learning in young children with ASD (relative to full, grammatical utterances). The proposed project will investigate three specific aims: 1) Determine how single-word and telegraphic simplification affects language processing. 2) Determine how single-word and telegraphic simplification affects word learning. 3) Evaluate child characteristics that may moderate the effects of linguistic simplification on language processing and word learning. Aim 1 will test the hypothesis that children with ASD will process full, grammatical utterances faster and more accurately than single-word or telegraphic utterances. Aim 2 will test the hypothesis that full, grammatical utterances will support word learning better than telegraphic or single-word utterances. Aim 3 will test the hypothesis that language and cognitive skills significantly moderate the effects of linguistic simplification on language processing and word learning in young children with ASD.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Simplified Language for Autism?
The pilot study on Expressive Language Sampling (ELS) suggests that parents can effectively learn and administer language tasks at home, which may help improve language skills in children with autism. This indicates that simplified language input, like the treatment in the trial, could be beneficial for enhancing communication in autistic individuals.12345
How does the treatment 'Simplified Language for Autism' differ from other treatments for autism?
The 'Simplified Language for Autism' treatment is unique because it uses telegraphic simplification, which involves using short, simple phrases to help children with language delays understand and communicate better. This approach is different from other treatments that may focus on more complex language structures or different therapeutic methods.678910
Research Team
Eligibility Criteria
This trial is for young children aged 1-4 who have been diagnosed with autism spectrum disorder or are suspected to have it, confirmed through ADOS-2. They must primarily speak English. Children with genetic conditions like Down syndrome, brain injuries, cerebral palsy, or uncorrected vision/hearing issues cannot participate.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Experimental Manipulation
Participants are exposed to all utterance types to evaluate language processing and word learning
Assessment
Gaze location is assessed during Looking-While-Listening tasks and Fast Mapping tasks
Follow-up
Participants are monitored for any changes in language processing and word learning post-intervention
Treatment Details
Interventions
- Linguistic simplification (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Michigan State University
Lead Sponsor
Doug Gage
Michigan State University
Chief Executive Officer
PhD in Botany from the University of Texas
David Smith
Michigan State University
Chief Medical Officer
MD from Michigan State University
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
Joshua M. Levy
National Institute on Deafness and Other Communication Disorders (NIDCD)
Chief Medical Officer
MD, MPH, MS
Debara L. Tucci
National Institute on Deafness and Other Communication Disorders (NIDCD)
Chief Executive Officer since 2019
MD, MS, MBA